Abstract
ObjectiveTo evaluate pathological complete response as a surrogate endpoint for disease-free survival and overall survival in regulatory neoadjuvant trials of early stage breast cancer.DesignSystematic review and meta-analysis.Data sourcesMedline, Embase, and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have